- 首頁
- App 分析
- Multiple Myeloma Management
- Multiple Myeloma Management Vs. HealthTree
Multiple Myeloma Management 與 HealthTree 使用情況與統計
Bispecific antibodies are a novel mechanism in the management in the relapsed/refractory multiple myeloma. Recognizing the mechanism of these agents as well as preliminary efficacy data is important in considering clinical trials and implementing approved bispecific antibodies in the management of multiple myeloma.
- Apple App Store
- 免費版
- 醫療
商店排名
- -
HealthTree is the one, easy-to-access app to learn about your blood cancer, find a community and unite with researchers to discover lifesaving treatments for diseases.
The HealthTree app brings all the features the HealthTree Foundation has to offer, including:
- Track your labs, genetics, and more from all of your facilities in one convenient place
- Find life-saving clinical trials perfect for you automatically
- Gain free access to step-by-step patient guides
- Get on-demand help from our patient navigators
- Find a free patient coach for all your needs
- Find a community, ask questions and share your story with others
- Learn from over 200+ specialists
- Join events, chapters and listen to expert podcasts
- Stay up-to-date on disease news and breakthroughs
- Participate in life-saving research
- Apple App Store
- 免費版
- 健康與健身
商店排名
- -
Multiple Myeloma Management與 HealthTree 比較排名
比較過去 28 天的 Multiple Myeloma Management 排名趨勢與 HealthTree
排名
無可用數據
各國 Multiple Myeloma Management vs. HealthTree 排名比較
比較過去 28 天的 Multiple Myeloma Management 排名趨勢與 HealthTree
無可顯示數據
使用我們的免費試用版,與所有網站進行比較
Multiple Myeloma Management VS.
HealthTree
12月 19, 2024